This inventor holds 7 USPTO granted patents. Top assignees: Adir Et Compagnie, Les Laboratories Servier, Les Laboratoires Servier. Active years: 1991-2008.
Location History:
- Le Havre, FR (1991 - 1994)
- Gruchet le Valasse, FR (2000 - 2008)
Company Filing History:
4 out of 368 
2 out of 53 
1 out of 296 
Years Active: 1991-2008
Title: Claude Fugier - Innovator in Pharmaceutical Synthesis
Introduction
Claude Fugier, a skilled inventor based in Gruchet le Valasse, France, has made significant contributions to the field of pharmaceutical chemistry. With a total of 7 patents to his name, Fugier has been instrumental in developing methods that enhance the synthesis of important pharmaceutical compounds, demonstrating his commitment to innovation in medicine.
Latest Patents
Fugier's recent patents showcase his expertise in the synthesis of perindopril, a medication used to treat high blood pressure and heart failure. His notable patents include:
- A method for the synthesis of perindopril and its pharmaceutically acceptable salts.
- A process for synthesizing esters of N-[(S)-1-carboxybutyl]-(S)-alanine, aimed at producing perindopril.
These advancements not only streamline the production process but also ensure the availability of high-quality compounds for therapeutic use.
Career Highlights
Throughout his career, Claude Fugier has worked with prominent companies, including Adir Et Compagnie and Les Laboratories Servier. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry, applying his inventive skills to practical applications.
Collaborations
Fugier's journey in innovation has also involved working alongside notable colleagues, such as Jean-Claude J Souvie and Jean-Pierre Lecouve. These collaborations have enriched his research endeavors, fostering a productive environment for the exchange of ideas and expertise in pharmaceutical development.
Conclusion
Claude Fugier exemplifies the spirit of innovation within the pharmaceutical industry. His dedication to the synthesis of critical compounds, along with his successful collaborations, marks him as a key figure in advancing healthcare solutions. As he continues to explore new methodologies, the impact of his inventions will undoubtedly be felt in the broader medical community.